Year: 2023
Type: article
Study design: Case Report
Abstract: Xeroderma pigmentosum (XP) is a rare, DNA repair defect syndrome that presents with significant sensitivity to UV exposure. Patients with XP have significantly increased risk of cutaneous tumors, specifically nonmelanoma and melanoma skin cancers.1,2 Cutaneous angiosarcoma is a rare, aggressive, vascular tumor that typically presents in sites of prior radiation or chronic UV exposure.3 Angiosarcoma in patients with XP presents a treatment conundrum as 1 of the main treatment approaches to angiosarcoma is radiation therapy, whereby the ionizing radiation poses a risk for further morbidity.
Source: JAAD Case Reports
Institutions: Harvard University, Massachusetts General Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $675
OpenAlex ID: W4386524601
